David Kliff

David Kliff is the author and publisher of the Diabetic Investor eNewsletter, with over 20 years of experience analyzing the diabetes industry. He focuses on the diabetes biomed, biotech, and device market, sharing insights on emerging trends in pharmaceutical and tech companies within this sector.

With a background as an investment advisor and as a person living with diabetes, David brings a unique perspective that combines financial expertise with personal experience. He is known for his candid and incisive commentary, challenging industry norms and providing a comprehensive overview of the diabetes landscape.

David excels in connecting different stakeholders in the diabetes field, including patients, industry players, researchers, and technology developers. His deep understanding of these intersections allows him to offer thought-provoking insights into the industry as a whole.